Optical imaging of bacterial infections

Clinical and Translational Imaging

Volumn 4, Issue 3, 2016, Pages 163-174

  Mills, Bethany ^a   Bradley, Mark ^a,b   Dhaliwal, Kevin ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Bacteria; Fluorescence; Imaging; Infection; Optical; Pre clinical

Indexed keywords

BETA LACTAMASE; CARBOCYANINE; CIPROFLOXACIN; CONCANAVALIN A; FLUORODEOXYGLUCOSE F 18; GLUCOSE 6 PHOSPHATE; NITROREDUCTASE; NUCLEASE; POLYPEPTIDE ANTIBIOTIC AGENT; PROTHROMBIN; TECHNETIUM 99M; VANCOMYCIN; ZINC;

BACTERIAL INFECTION; BACTERIOPHAGE; CHEMICAL PHENOMENA; CONFOCAL MICROSCOPY; ESCHERICHIA COLI; FLUORESCENCE IMAGING; FLUORESCENCE RESONANCE ENERGY TRANSFER; FOOD AND DRUG ADMINISTRATION; HUMAN; MOLECULAR IMAGING; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

EID: 85006210700     PISSN: 22815872     EISSN: 22817565     Source Type: Journal    
DOI: 10.1007/s40336-016-0180-0     Document Type: Review

References (111)

1. CDC (2013) Antibiotic resistance threats in the United States. Centers for Disease Control and Prevention, USA
2. ECDC (2009) The bacterial challenge: time to react. European Centre for Disease Prevention and Control, Stockholm
3. WHO (2014) Antimicrobial resistance: global report on surveillance 2014. World Health Organisation, Geneva. URL: http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748_eng.pdf?ua=1
4. Beceiro A, Tomás M, Bou G (2013) Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world? Clin Microbiol Rev 26(2):185–230
5. ECDC (2012) Antimicrobial resistance surveillance in Europe 2011. European Centre for Disease Prevention and Control, Stockholm
6. ECDC (2013) Antimicrobial resistance surveillance in Europe 2012. European Centre for Disease Prevention and Control, Stockholm
7. WHO (2015) Global action plan on antimicrobial resistance. World Health Organisation, Geneva 2015. URL: http://apps.who.int/iris/bitstream/10665/193736/1/9789241509763_eng.pdf?ua=1
8. Friedman ND, Temkin E, Carmeli Y (2016) The negative impact of antibiotic resistance. Clin Microbiol Infect. doi:10.1016/j.cmi.2015.12.002
9. Chacko TK, Zhuang H, Nakhoda KZ, Moussavian B, Alavi A (2003) Applications of fluorodeoxyglucose positron emission tomography in the diagnosis of infection. Nucl Med Commun 24(6):615–624
10. De Winter F, Vogelaers D, Gemmel F, Dierckx RA (2002) Promising role of 18-F-fluoro-d-deoxyglucose positron emission tomography in clinical infectious diseases. Eur J Clin Microbiol Infect Dis 21(4):247–257
11. Kwee TC, Kwee RM, Alavi A (2008) FDG-PET for diagnosing prosthetic joint infection: systematic review and metaanalysis. Eur J Nucl Med Mol Imaging 35(11):2122–2132
12. Stumpe KD, Dazzi H, Schaffner A, von Schulthess GK (2000) Infection imaging using whole-body FDG-PET. Eur J Nucl Med 27(7):822–832
13. Haroon A, Zumla A, Bomanji J (2012) Role of fluorine 18 fluorodeoxyglucose positron emission tomography-computed tomography in focal and generalized infectious and inflammatory disorders. Clin Infect Dis 54(9):1333–1341
14. Zhuang H, Duarte PS, Pourdehnad M, Maes A, Van Acker F, Shnier D, Garino JP, Fitzgerald RH, Alavi A (2001) The promising role of 18F-FDG PET in detecting infected lower limb prosthesis implants. J Nucl Med 42(1):44–48
15. Zhuang H, Yu JQ, Alavi A (2005) Applications of fluorodeoxyglucose-PET imaging in the detection of infection and inflammation and other benign disorders. Radiol Clin North Am 43(1):121–134
16. Signore A, Glaudemans AW (2011) The molecular imaging approach to image infections and inflammation by nuclear medicine techniques. Ann Nucl Med 25(10):681–700
17. Palestro CJ, Love C, Bhargava KK (2009) Labeled leukocyte imaging: current status and future directions. Q J Nucl Med Mol Imaging 53(1):105–123
18. Kumar V (2005) Radiolabeled white blood cells and direct targeting of micro-organisms for infection imaging. Q J Nucl Med Mol Imaging 49(4):325–338
19. Aksoy SY, Asa S, Ozhan M, Ocak M, Sager MS, Erkan ME, Halac M, Kabasakal L, Sonmezoglu K, Kanmaz B (2014) FDG and FDG-labelled leucocyte PET/CT in the imaging of prosthetic joint infection. Eur J Nucl Med Mol Imaging 41(3):556–564
20. Palestro CJ (2014) Nuclear medicine and the failed joint replacement: past, present, and future. World J Radiol 6(7):446–458
21. Glaudemans AW, Galli F, Pacilio M, Signore A (2013) Leukocyte and bacteria imaging in prosthetic joint infection. Eur Cell Mater 25:61–77
22. Liu X, Cheng D, Gray BD, Wang Y, Akalin A, Rusckowski M, Pak KY, Hnatowich DJ (2012) Radiolabeled Zn-DPA as a potential infection imaging agent. Nucl Med Biol 39(5):709–714
23. Nibbering PH, Welling MM, Paulusma-Annema A, Brouwer CPJM, Lupetti A, Pauwels EKJ (2004) 99mTc-Labeled UBI 29–41 peptide for monitoring the efficacy of antibacterial agents in mice infected with Staphylococcus aureus. J Nucl Med 45(2):321–326
24. Welling MM, Lupetti A, Balter HS, Lanzzeri S, Souto B, Rey AM, Savio EO, Paulusma-Annema A, Pauwels EK, Nibbering PH (2001) 99mTc-labeled antimicrobial peptides for detection of bacterial and Candida albicans infections. J Nucl Med 42(5):788–794
25. Welling MM, Mongera S, Lupetti A, Balter HS, Bonetto V, Mazzi U, Pauwels EK, Nibbering PH (2002) Radiochemical and biological characteristics of 99mTc-UBI 29–41 for imaging of bacterial infections. Nucl Med Biol 29(4):413–422
26. Akhtar M, Khan M, Khan B, Irfanullah J, Afzal M, Khan M, Nadeem M, Jehangir M, Imran M (2008) An imaging analysis of 99mTc-UBI (29–41) uptake in S. aureus infected thighs of rabbits on ciprofloxacin treatment. Eur J Nucl Med Mol Imaging 35(6):1056–1064
27. Akhtar MS, Qaisar A, Irfanullah J, Iqbal J, Khan B, Jehangir M, Nadeem MA, Khan MA, Afzal MS, Ul-Haq I et al (2005) Antimicrobial peptide 99mTc-ubiquicidin 29–41 as human infection-imaging agent: clinical trial. J Nucl Med 46(4):567–573
28. Brouwer CP, Gemmel FF, Welling MM (2010) Evaluation of 99mTc-UBI 29–41 scintigraphy for specific detection of experimental multidrug-resistant Staphylococcus aureus bacterial endocarditis. Q J Nucl Med Mol Imaging 54(4):442–450
29. Davis SL, Be NA, Lamichhane G, Nimmagadda S, Pomper MG, Bishai WR, Jain SK (2009) Bacterial thymidine kinase as a non-invasive imaging reporter for Mycobacterium tuberculosis in live animals. PLoS One 4(7):e6297
30. Cho S, Yung R, Jeffrey-Kwanisai A, Foss C, Nimmagadda S, Pomper M (2013) 124I-FIAU thymidine kinase-based PET imaging of lung infection. J Nucl Med Meet Abstr 54:649
31. Pullambhatla M, Tessier J, Beck G, Jedynak B, Wurthner JU, Pomper MG (2012) [(125)I]FIAU imaging in a preclinical model of lung infection: quantification of bacterial load. Am J Nucl Med Mol Imaging 2(3):260–270
32. Signore A, Lauri C, Galli F (2014) Radiolabelled probes targeting infection and inflammation for personalized medicine. Curr Pharm Des 20(14):2338–2345
33. Sasser TA, Van Avermaete AE, White A, Chapman S, Johnson JR, Van Avermaete T, Gammon ST, Leevy WM (2013) Bacterial infection probes and imaging strategies in clinical nuclear medicine and preclinical molecular imaging. Curr Top Med Chem 13(4):479–487
34. Keereweer S, Van Driel PB, Snoeks TJ, Kerrebijn JD, Baatenburg de Jong RJ, Vahrmeijer AL, Sterenborg HJ, Lowik CW (2013) Optical image-guided cancer surgery: challenges and limitations. Clin Cancer Res 19(14):3745–3754
35. Vahrmeijer AL, Hutteman M, van der Vorst JR, van de Velde CJ, Frangioni JV (2013) Image-guided cancer surgery using near-infrared fluorescence. Nat Rev Clin Oncol 10(9):507–518
36. Gioux S, Choi HS, Frangioni JV (2010) Image-guided surgery using invisible near-infrared light: fundamentals of clinical translation. Mol Imaging 9(5):237–255
37. Escobedo JO, Rusin O, Lim S, Strongin RM (2010) NIR dyes for bioimaging applications. Curr Opin Chem Biol 14(1):64–70
38. Koide Y, Urano Y, Hanaoka K, Piao W, Kusakabe M, Saito N, Terai T, Okabe T, Nagano T (2012) Development of NIR fluorescent dyes based on Si-rhodamine for in vivo imaging. J Am Chem Soc 134(11):5029–5031
39. Su D, Teoh CL, Samanta A, Kang NY, Park SJ, Chang YT (2015) The development of a highly photostable and chemically stable zwitterionic near-infrared dye for imaging applications. Chem Commun (Camb) 51(19):3989–3992
40. Jacques SL (2013) Optical properties of biological tissues: a review. Phys Med Biol 58(11):R37–R61
41. Welsher K, Sherlock SP, Dai H (2011) Deep-tissue anatomical imaging of mice using carbon nanotube fluorophores in the second near-infrared window. Proc Natl Acad Sci USA 108(22):8943–8948
42. Stolik S, Delgado JA, Perez A, Anasagasti L (2000) Measurement of the penetration depths of red and near infrared light in human “ex vivo” tissues. J Photochem Photobiol B 57(2–3):90–93
43. Alander JT, Kaartinen I, Laakso A, Patila T, Spillmann T, Tuchin VV, Venermo M, Valisuo P (2012) A review of indocyanine green fluorescent imaging in surgery. Int J Biomed Imaging 2012:940585
44. Chattopadhyay A (1990) Chemistry and biology of N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)-labeled lipids: fluorescent probes of biological and model membranes. Chem Phys Lipids 53(1):1–15
45. Akram AR, Avlonitis N, Lilienkampf A, Perez-Lopez AM, McDonald N, Chankeshwara SV, Scholefield E, Haslett C, Bradley M, Dhaliwal K (2015) A labelled-ubiquicidin antimicrobial peptide for immediate in situ optical detection of live bacteria in human alveolar lung tissue. Chem Sci 6(12):6971–6979
46. Kong Y, Yao H, Ren H, Subbian S, Cirillo SL, Sacchettini JC, Rao J, Cirillo JD (2010) Imaging tuberculosis with endogenous beta-lactamase reporter enzyme fluorescence in live mice. Proc Natl Acad Sci USA 107(27):12239–12244
47. Hernandez FJ, Huang L, Olson ME, Powers KM, Hernandez LI, Meyerholz DK, Thedens DR, Behlke MA, Horswill AR, McNamara JO 2nd (2014) Noninvasive imaging of Staphylococcus aureus infections with a nuclease-activated probe. Nat Med 20(3):301–306
48. Saeed S, Zafar J, Khan B, Akhtar A, Qurieshi S, Fatima S, Ahmad N, Irfanullah J (2013) Utility of 99mTc-labelled antimicrobial peptide ubiquicidin (29–41) in the diagnosis of diabetic foot infection. Eur J Nucl Med Mol Imaging 40(5):737–743
49. Sepulveda-Mendez J, de Murphy CA, Rojas-Bautista JC, Pedraza-Lopez M (2010) Specificity of 99mTc-UBI for detecting infection foci in patients with fever in study. Nucl Med Commun 31(10):889–895
50. Assadi M, Vahdat K, Nabipour I, Sehhat MR, Hadavand F, Javadi H, Tavakoli A, Saberifard J, Kalantarhormozi MR, Zakani A et al (2011) Diagnostic value of 99mTc-ubiquicidin scintigraphy for osteomyelitis and comparisons with 99mTc-methylene diphosphonate scintigraphy and magnetic resonance imaging. Nucl Med Commun 32(8):716–723
51. Aryana K, Hootkani A, Sadeghi R, Davoudi Y, Naderinasab M, Erfani M, Ayati N (2012) (99m)Tc-labeled ubiquicidin scintigraphy: a promising method in hip prosthesis infection diagnosis. Nuklearmedizin 51(4):133–139
52. Nazari B, Azizmohammadi Z, Rajaei M, Karami M, Javadi H, Assadi M, Asli IN (2011) Role of 99mTc-ubiquicidin 29–41 scintigraphy to monitor antibiotic therapy in patients with orthopedic infection: a preliminary study. Nucl Med Commun 32(8):745–751
53. Chen H, Liu C, Chen D, Madrid K, Peng S, Dong X, Zhang M, Gu Y (2015) Bacteria-targeting conjugates based on antimicrobial peptide for bacteria diagnosis and therapy. Mol Pharm 12(7):2505–2516
54. Chen H, Zhang M, Li B, Chen D, Dong X, Wang Y, Gu Y (2015) Versatile antimicrobial peptide-based ZnO quantum dots for in vivo bacteria diagnosis and treatment with high specificity. Biomaterials 53:532–544
55. Welling MM, Bunschoten A, Kuil J, Nelissen RG, Beekman FJ, Buckle T, van Leeuwen FW (2015) Development of a hybrid tracer for SPECT and optical imaging of bacterial infections. Bioconjug Chem 26(5):839–849
56. van den Berg NS, Brouwer OR, Schaafsma BE, Matheron HM, Klop WM, Balm AJ, van Tinteren H, Nieweg OE, van Leeuwen FW, Valdes Olmos RA (2015) Multimodal surgical guidance during sentinel node biopsy for melanoma: combined gamma tracing and fluorescence imaging of the sentinel node through use of the hybrid tracer indocyanine green-(99m)Tc-nanocolloid. Radiology 275(2):521–529
57. Brouwer OR, van den Berg NS, Matheron HM, van der Poel HG, van Rhijn BW, Bex A, van Tinteren H, Valdes Olmos RA, van Leeuwen FW, Horenblas S (2014) A hybrid radioactive and fluorescent tracer for sentinel node biopsy in penile carcinoma as a potential replacement for blue dye. Eur Urol 65(3):600–609
58. Leevy WM, Johnson JR, Lakshmi C, Morris J, Marquez M, Smith BD (2006) Selective recognition of bacterial membranes by zinc(II)-coordination complexes. Chem Commun 15:1595–1597
59. DiVittorio KM, Leevy WM, O’Neil EJ, Johnson JR, Vakulenko S, Morris JD, Rosek KD, Serazin N, Hilkert S, Hurley S et al (2008) Zinc(II) coordination complexes as membrane-active fluorescent probes and antibiotics. Chembiochem 9(2):286–293
60. White AG, Gray BD, Pak KY, Smith BD (2012) Deep-red fluorescent imaging probe for bacteria. Bioorg Med Chem Lett 22(8):2833–2836
61. Leevy WM, Gammon ST, Jiang H, Johnson JR, Maxwell DJ, Jackson EN, Marquez M, Piwnica-Worms D, Smith BD (2006) Optical imaging of bacterial infection in living mice using a fluorescent near-infrared molecular probe. J Am Chem Soc 128(51):16476–16477
62. Leevy WM, Gammon ST, Johnson JR, Lampkins AJ, Jiang H, Marquez M, Piwnica-Worms D, Suckow MA, Smith BD (2008) Noninvasive optical imaging of Staphylococcus aureus bacterial infection in living mice using a bis-dipicolylamine-zinc(II) affinity group conjugated to a near-infrared fluorophore. Bioconjug Chem 19(3):686–692
63. Johnson JR, Fu N, Arunkumar E, Leevy WM, Gammon ST, Piwnica-Worms D, Smith BD (2007) Squaraine rotaxanes: superior substitutes for Cy-5 in molecular probes for near-infrared fluorescence cell imaging. Angew Chem Int Ed Engl 46(29):5528–5531
64. White AG, Fu N, Leevy WM, Lee JJ, Blasco MA, Smith BD (2010) Optical imaging of bacterial infection in living mice using deep-red fluorescent squaraine rotaxane probes. Bioconjug Chem 21(7):1297–1304
65. Hanshaw RG, Lakshmi C, Lambert TN, Johnson JR, Smith BD (2005) Fluorescent detection of apoptotic cells by using zinc coordination complexes with a selective affinity for membrane surfaces enriched with phosphatidylserine. Chembiochem 6(12):2214–2220
66. Thakur ML, Zhang K, Paudyal B, Devakumar D, Covarrubias M, Cheng C, Gray B, Wickstrom E, Pak K (2012) Targeting apoptosis for optical imaging of infection. Mol Imaging Biol 14(2):163–171
67. Dahl MK, Manson MD (1985) Interspecific reconstitution of maltose transport and chemotaxis in Escherichia coli with maltose-binding protein from various enteric bacteria. J Bacteriol 164(3):1057–1063
68. Boos W, Shuman H (1998) Maltose/maltodextrin system of Escherichia coli: transport, metabolism, and regulation. Microbiol Mol Biol Rev 62(1):204–229
69. Gopal S, Berg D, Hagen N, Schriefer EM, Stoll R, Goebel W, Kreft J (2010) Maltose and maltodextrin utilization by Listeria monocytogenes depend on an inducible ABC transporter which is repressed by glucose. PLoS One 5(4):e10349
70. Reuss R, Ludwig J, Shirakashi R, Ehrhart F, Zimmermann H, Schneider S, Weber MM, Zimmermann U, Schneider H, Sukhorukov VL (2004) Intracellular delivery of carbohydrates into mammalian cells through swelling-activated pathways. J Membr Biol 200(2):67–81
71. Ning X, Lee S, Wang Z, Kim D, Stubblefield B, Gilbert E, Murthy N (2011) Maltodextrin-based imaging probes detect bacteria in vivo with high sensitivity and specificity. Nat Mater 10(8):602–607
72. Winkler HH (1973) Distribution of an inducible hexose-phosphate transport system among various bacteria. J Bacteriol 116(2):1079–1081
73. Murphy AG, O’Keeffe KM, Lalor SJ, Maher BM, Mills KH, McLoughlin RM (2015) Correction: Staphylococcus aureus infection of mice expands a population of memory gammadelta T cells that are protective against subsequent infection. J Immunol 194(9):4588
74. Zou C, Wang Y, Shen Z (2005) 2-NBDG as a fluorescent indicator for direct glucose uptake measurement. J Biochem Biophys Methods 64(3):207–215
75. O’Neil RG, Wu L, Mullani N (2005) Uptake of a fluorescent deoxyglucose analog (2-NBDG) in tumor cells. Mol Imaging Biol 7(6):388–392
76. Cheng Z, Levi J, Xiong Z, Gheysens O, Keren S, Chen X, Gambhir SS (2006) Near-infrared fluorescent deoxyglucose analogue for tumor optical imaging in cell culture and living mice. Bioconjug Chem 17(3):662–669
77. Tseng JC, Wang Y, Banerjee P, Kung AL (2012) Incongruity of imaging using fluorescent 2-DG conjugates compared to 18F-FDG in preclinical cancer models. Mol Imaging Biol 14(5):553–560
78. Isono M, Nakanishi I, Sasajima K-I, Motizuki K, Kanzaki T, Okazaki H, Yoshino H (1968) 2-keto-l-gulonic acid fermentation. Part I. Paper chromatographic characterization of metabolic products from sorbitol and l-sorbose by various bacteria. Agric Biol Chem 32(4):424–431
79. Weinstein EA, Ordonez AA, DeMarco VP, Murawski AM, Pokkali S, MacDonald EM, Klunk M, Mease RC, Pomper MG, Jain SK (2014) Imaging Enterobacteriaceae infection in vivo with 18F-fluorodeoxysorbitol positron emission tomography. Sci Transl Med 6(259):259ra146
80. Yao S, Xing H, Zhu W, Wu Z, Zhang Y, Ma Y, Liu Y, Huo L, Zhu Z, Li Z et al (2015) Infection imaging with [18F]-FDS and first-in-human evaluation. Nucl Med Biol 43(3):206–214
81. Tang EN, Nair A, Baker DW, Hu W, Zhou J (2014) In vivo imaging of infection using a bacteria-targeting optical nanoprobe. J Biomed Nanotechnol 10(5):856–863
82. Hernandez FJ, Stockdale KR, Huang L, Horswill AR, Behlke MA, McNamara JO 2nd (2012) Degradation of nuclease-stabilized RNA oligonucleotides in Mycoplasma-contaminated cell culture media. Nucleic Acid Ther 22(1):58–68
83. Knox JR, Moews PC, Frere JM (1996) Molecular evolution of bacterial beta-lactam resistance. Chem Biol 3(11):937–947
84. Hermann JC, Ridder L, Holtje HD, Mulholland AJ (2006) Molecular mechanisms of antibiotic resistance: QM/MM modelling of deacylation in a class A beta-lactamase. Org Biomol Chem 4(2):206–210
85. Davies J (1994) Inactivation of antibiotics and the dissemination of resistance genes. Science 264(5157):375–382
86. Fisher JF, Mobashery S (2009) Three decades of the class A beta-lactamase acyl-enzyme. Curr Protein Pept Sci 10(5):401–407
87. Wang F, Cassidy C, Sacchettini JC (2006) Crystal structure and activity studies of the Mycobacterium tuberculosis beta-lactamase reveal its critical role in resistance to beta-lactam antibiotics. Antimicrob Agents Chemother 50(8):2762–2771
88. Campbell RE (2004) Realization of beta-lactamase as a versatile fluorogenic reporter. Trends Biotechnol 22(5):208–211
89. Friedrich R, Panizzi P, Fuentes-Prior P, Richter K, Verhamme I, Anderson PJ, Kawabata S, Huber R, Bode W, Bock PE (2003) Staphylocoagulase is a prototype for the mechanism of cofactor-induced zymogen activation. Nature 425(6957):535–539
90. Panizzi P, Friedrich R, Fuentes-Prior P, Richter K, Bock PE, Bode W (2006) Fibrinogen substrate recognition by staphylocoagulase. (pro)thrombin complexes. J Biol Chem 281(2):1179–1187
91. Loeb L (1903) The influence of certain bacteria on the coagulation of the blood. J Med Res 10(3):407–419
92. Panizzi P, Nahrendorf M, Figueiredo JL, Panizzi J, Marinelli B, Iwamoto Y, Keliher E, Maddur AA, Waterman P, Kroh HK et al (2011) In vivo detection of Staphylococcus aureus endocarditis by targeting pathogen-specific prothrombin activation. Nat Med 17(9):1142–1146
93. Stanton M, Cronin M, Lehouritis P, Tangney M (2015) In vivo bacterial imaging without engineering; a novel probe-based strategy facilitated by endogenous nitroreductase enzymes. Curr Gene Ther 15(3):277–288
94. Roldan MD, Perez-Reinado E, Castillo F, Moreno-Vivian C (2008) Reduction of polynitroaromatic compounds: the bacterial nitroreductases. FEMS Microbiol Rev 32(3):474–500
95. Mirshojaei SF (2015) Advances in infectious foci imaging using 99mTc radiolabelled antibiotics. J Radioanal Nucl Chem 304(3):975–988
96. Hall AV, Solanki KK, Vinjamuri S, Britton KE, Das SS (1998) Evaluation of the efficacy of 99mTc-Infecton, a novel agent for detecting sites of infection. J Clin Pathol 51(3):215–219
97. Solanki K, Bomanji J, Siraj Q, Small M, Britton K (1993) Tc-99m Infecton-a new class of radiopharmaceutical for imaging infection. J Nucl Med (abstract) 34(5):P119
98. Sarda L, Saleh-Mghir A, Peker C, Meulemans A, Cremieux AC, Le Guludec D (2002) Evaluation of (99m)Tc-ciprofloxacin scintigraphy in a rabbit model of Staphylococcus aureus prosthetic joint infection. J Nucl Med 43(2):239–245
99. Peremans K, De Winter F, Janssens L, Dumont F, Van Bree H, Dierckx R (2002) An infected hip prosthesis in a dog diagnosed with a 99mTc-ciprofloxacin (infecton) scan. Vet Radiol Ultrasound 43(2):178–182
100. Sarda L, Cremieux AC, Lebellec Y, Meulemans A, Lebtahi R, Hayem G, Genin R, Delahaye N, Huten D, Le Guludec D (2003) Inability of 99mTc-ciprofloxacin scintigraphy to discriminate between septic and sterile osteoarticular diseases. J Nucl Med 44(6):920–926
101. Malamitsi J, Giamarellou H, Kanellakopoulou K, Dounis E, Grecka V, Christakopoulos J, Koratzanis G, Antoniadou A, Panoutsopoulos G, Batsakis C et al (2003) Infecton: a 99mTc-ciprofloxacin radiopharmaceutical for the detection of bone infection. Clin Microbiol Infect 9(2):101–109
102. Hiramatsu K (2001) Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect Dis 1(3):147–155
103. van Oosten M, Schafer T, Gazendam JA, Ohlsen K, Tsompanidou E, de Goffau MC, Harmsen HJ, Crane LM, Lim E, Francis KP et al (2013) Real-time in vivo imaging of invasive- and biomaterial-associated bacterial infections using fluorescently labelled vancomycin. Nat Commun 4:2584
104. Kohanski MA, DePristo MA, Collins JJ (2010) Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis. Mol Cell 37(3):311–320
105. Silverman PM, Clarke MB (2010) New insights into F-pilus structure, dynamics, and function. Integr Biol (Camb) 2(1):25–31
106. O’Callaghan R, Bradley R, Paranchych W (1973) The effect of M13 phage infection upon the F pili of E. coli. Virology 54(1):220–229
107. Bardhan NM, Ghosh D, Belcher AM (2014) Carbon nanotubes as in vivo bacterial probes. Nat Commun 5:4918
108. Weissleder R (2001) A clearer vision for in vivo imaging. Nat Biotechnol 19(4):316–317
109. Smith AM, Mancini MC, Nie S (2009) Bioimaging: second window for in vivo imaging. Nat Nanotechnol 4(11):710–711
110. Troy TL, Thennadil SN (2001) Optical properties of human skin in the near infrared wavelength range of 1000 to 2200 nm. J Biomed Opt 6(2):167–176
111. Lim YT, Kim S, Nakayama A, Stott NE, Bawendi MG, Frangioni JV (2003) Selection of quantum dot wavelengths for biomedical assays and imaging. Mol Imaging 2(1):50–64